STAAR Surgical Company Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 28
STAAR Surgical Company Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1 2
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
3 STAAR Surgical Company Pipeline Products 8
3.1 STAAR Surgical Company Product Pipeline Analysis 8
3.1.1 STAAR Surgical Company Pipeline Products By Equipment Type 8
3.1.2 STAAR Surgical Company Pipeline Products By Development Stage 8
3.1.3 STAAR Surgical Company Pipeline Products By Therapy Area 9
3.1.4 STAAR Surgical Company Pipeline Products By Clinical Trials 9
3.1.5 STAAR Surgical Company Pipeline Products By News Summary 9
3.2 Canon-STAAR Preloaded IOL (Model KS-3Ai) 10
3.2.1 Product Status 10
3.2.2 Product Description 10
3.3 2.0 mm micro-incision injector system 10
3.3.1 Product Status 10
3.3.2 Product Description 11
3.4 TORIC Collamer plate IOL 11
3.4.1 Product Status 11
3.4.2 Product Description 11
3.5 Intraocular refractive implant 11
3.5.1 Product Status 11
3.5.2 Product Description 12
3.5.3 Product Institution Details 12
3.6 Injector system 12
3.6.1 Product Status 12
3.6.2 Product Description 12
3.7 Preloaded IOL injector system 13
3.7.1 Product Status 13
3.7.2 Product Description 13
3.7.3 Product Milestone 13
3.8 Preloaded IOL Injector System for Silicone Aspheric IOL 14
3.8.1 Product Status 14
3.8.2 Product Description 14
3.8.3 Product Milestone 14
3.9 STAAR Visian Toric Implantable Collamer Lens 15
3.9.1 Product Status 15
3.9.2 Product Description 15
3.9.3 Product Milestone 15
3.9.4 STAAR Visian Toric Implantable Collamer LensClinical Trials 1 16
3.9.5 STAAR Visian Toric Implantable Collamer LensClinical Trials 2 17
3.9.6 STAAR Visian Toric Implantable Collamer LensClinical Trials 3 18
3.9.7 STAAR Visian Toric Implantable Collamer LensClinical Trials 4 19
3.9.8 STAAR Visian Toric Implantable Collamer LensClinical Trials 5 19
4 Recent Developments 20
4.1 Product News 20
4.1.1 Aug 07, 2008: STAAR Surgicals VISIAN ICL To Be Featured On CBS Early Show 20
4.1.2 Jun 12, 2008: STAAR Surgical Company (STAA)s LASIK Alternative Expands US Market Gains 20
4.1.3 Mar 04, 2008: STAAR Surgicals Visian ICL Procedure Performed Live On NBCs Today Show 21
4.1.4 Feb 29, 2008: STAAR Surgical Receives Approval To Market Visian Toric Implantable Collamer Lens In China 21
4.1.5 Feb 06, 2007: STAAR Surgical Provides Update On Toric ICL Application With FDA 21
4.1.6 Jul 31, 2006: STAAR Surgical Receives Approval To Market Visian ICL In China 22
4.1.7 May 04, 2006: STAAR Surgical Receives CE Mark Approval For Preloaded Aspheric Silicone IOL 22
4.1.8 Apr 28, 2006: STAAR Surgical Submits Application To FDA For The Visian Toric ICL 22
4.1.9 Jan 11, 2006: STAAR Surgical Announces First Implant For Myopia Treatment 23
4.1.10 Dec 23, 2005: STAAR Surgicals VISIAN ICL Receives FDA Approval 23
4.2 Product Approvals 24
4.2.1 Feb 29, 2008: STAAR Surgical Receives Approval To Market Visian Toric Implantable Collamer Lens In China 24
4.2.2 Jul 31, 2006: STAAR Surgical Receives Approval To Market Visian ICL In China 24
4.2.3 May 04, 2006: STAAR Surgical Receives CE Mark Approval For Preloaded Aspheric Silicone IOL 24
4.2.4 Dec 23, 2005: STAAR Surgicals VISIAN ICL Receives FDA Approval 24
4.3 Clinical Trials 25
4.3.1 Jan 11, 2006: STAAR Surgical Announces First Implant For Myopia Treatment 25
5 Appendix 26
5.1 Methodology 26
5.1.1 Coverage 26
5.1.2 Secondary Research 27
5.1.3 Primary Research 27
5.1.4 Expert Panel Validation 28
5.2 Contact Us 28
5.3 About us28
5.4 Disclaimer 28
Executive Summary
1.2 List of Figures
Figure 1: Global Markets Direct Methodology 26
The following companies are the major competitors of STAAR Surgical Company:
Advanced Medical Optics, Inc.
Alcon Laboratories, Inc.
Bausch & Lomb Incorporated
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network